Skip to main content
. 2013 Dec 12;2(2):265–268. doi: 10.3892/mco.2013.226

Table II.

Performance characteristics of serum biomarkers for distinguishing pancreatic cancer from benign pancreatic diseases.

Markers ROC area (%) 95% CI Sensitivity (%) Specificity (%)
CA19-9 83.8a (76.8–89.4) 73.3 85.7
CA125 60.2a (51.7–68.2) 30.7 88.6
CA72-4 78.7a (71.2–85.1) 71.4 87.1
CA19-9 + CA72-4 89.5 (83.3–94.0) 70.6 92.8
a

P<0.05 compared with CA19-9 + CA72-4.

ROC, receiver operating characteristic; CI, confidence interval.